Jyothy Laboratories Intrinsic Value
Jyothy Laboratories intrinsic value. Jyothy Laboratories (JYOTHYLAB) median intrinsic value is ₹361.86 from 10 valuation models (range ₹54–₹452), vs current price ₹180.93 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit Jyothy Laboratories share price screener.
JYOTHYLAB Valuation Methods Summary — DCF, Graham Number & P/E
Jyothy Laboratories intrinsic value across 10 models vs current price ₹180.93 — upside/downside and value range per method. Compare with JYOTHYLAB fair value estimate to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹208.00 | ₹166.40 - ₹249.60 | +15.0% | EPS: ₹8.32, Sector P/E: 25x |
| Book Value Method | asset | ₹452.33 | ₹407.10 - ₹497.56 | +150.0% | Book Value/Share: ₹554.05, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹361.86 | ₹325.67 - ₹398.05 | +100.0% | Revenue/Share: ₹737.30, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹361.86 | ₹325.67 - ₹398.05 | +100.0% | EBITDA: ₹492.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹452.33 | ₹361.86 - ₹542.80 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹54.28 | ₹48.85 - ₹59.71 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹154.25 | ₹138.83 - ₹169.68 | -14.7% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹361.86 | ₹325.67 - ₹398.05 | +100.0% | ROE: 14.8%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹322.05 | ₹289.85 - ₹354.26 | +78.0% | EPS: ₹8.32, BVPS: ₹554.05 |
| Dividend Yield Method | dividend | ₹116.67 | ₹105.00 - ₹128.34 | -35.5% | DPS: ₹3.50, Target Yield: 3.0% |
JYOTHYLAB Intrinsic Value vs Market Price — All Valuation Models
Jyothy Laboratories fair value range ₹54–₹452 vs current market price ₹180.93 across 10 valuation models. Read JYOTHYLAB dividend yield for the complete payout history and dividend yield track record.
JYOTHYLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Jyothy Laboratories median intrinsic value ₹361.86, current price ₹180.93 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of JYOTHYLAB?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Jyothy Laboratories (JYOTHYLAB) is ₹361.86 (median value). With the current market price of ₹180.93, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹54.28 to ₹452.33, indicating ₹54.28 - ₹452.33.
Is JYOTHYLAB undervalued or overvalued?
Based on our multi-method analysis, Jyothy Laboratories (JYOTHYLAB) appears to be trading below calculated value by approximately 100.0%.
JYOTHYLAB Financial Health — Key Ratios vs Industry Benchmarks
Jyothy Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 10.77 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.8% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.01x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
JYOTHYLAB Cash Flow Quality — Operating & Free Cash Flow
Jyothy Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹311 Cr | ₹231 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹458 Cr | ₹286 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹329 Cr | ₹305 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹203 Cr | ₹187 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹402 Cr | ₹338 Cr | Positive Free Cash Flow | 8/10 |